Suraj Kalia
Stock Analyst at Oppenheimer
(3.62)
# 795
Out of 4,876 analysts
79
Total ratings
45.59%
Success rate
8.46%
Average return
Main Sectors:
Stocks Rated by Suraj Kalia
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TMDX TransMedics Group | Maintains: Outperform | $130 → $150 | $130.06 | +15.33% | 11 | Jun 17, 2025 | |
| ATRC AtriCure | Maintains: Outperform | $36 → $45 | $32.88 | +36.86% | 7 | Feb 13, 2025 | |
| VREX Varex Imaging | Maintains: Outperform | $30 → $23 | $8.55 | +169.01% | 6 | Feb 7, 2025 | |
| IRTC iRhythm Technologies | Maintains: Outperform | $105 → $120 | $152.69 | -21.41% | 5 | Jan 8, 2025 | |
| AORT Artivion | Maintains: Outperform | $30 → $32 | $30.62 | +4.51% | 3 | Nov 8, 2024 | |
| LMAT LeMaitre Vascular | Reiterates: Outperform | $90 → $93 | $82.40 | +12.86% | 2 | Nov 1, 2024 | |
| ABT Abbott Laboratories | Initiates: Outperform | $130 | $133.67 | -2.75% | 1 | Oct 8, 2024 | |
| TLSI TriSalus Life Sciences | Initiates: Outperform | $10 | $5.07 | +97.24% | 1 | Sep 16, 2024 | |
| EW Edwards Lifesciences | Maintains: Outperform | $90 | $77.15 | +16.66% | 5 | Sep 12, 2024 | |
| NYXH Nyxoah | Maintains: Outperform | $15 → $13 | $7.68 | +69.27% | 4 | Aug 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $135 | $121.87 | +10.77% | 1 | Jul 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Perform | n/a | $256.21 | - | 6 | Jun 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $24 → $30 | $10.25 | +192.68% | 5 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $16 → $10 | $0.16 | +6,023.70% | 1 | Jun 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $97 | $74.86 | +29.58% | 1 | May 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $28 | $21.48 | +30.35% | 4 | Mar 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $4.5 | $2.02 | +122.77% | 1 | Nov 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $16 | $2.22 | +620.72% | 1 | Sep 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Perform | n/a | $534.19 | - | 3 | Apr 21, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $660 | $2.20 | +29,900.00% | 2 | Nov 17, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Perform | n/a | $129.71 | - | 2 | Nov 3, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Perform | n/a | $5.38 | - | 1 | Sep 15, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $100 | $30.50 | +227.87% | 1 | Jun 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Market Perform | n/a | $85.04 | - | 5 | Sep 12, 2018 |
TransMedics Group
Jun 17, 2025
Maintains: Outperform
Price Target: $130 → $150
Current: $130.06
Upside: +15.33%
AtriCure
Feb 13, 2025
Maintains: Outperform
Price Target: $36 → $45
Current: $32.88
Upside: +36.86%
Varex Imaging
Feb 7, 2025
Maintains: Outperform
Price Target: $30 → $23
Current: $8.55
Upside: +169.01%
iRhythm Technologies
Jan 8, 2025
Maintains: Outperform
Price Target: $105 → $120
Current: $152.69
Upside: -21.41%
Artivion
Nov 8, 2024
Maintains: Outperform
Price Target: $30 → $32
Current: $30.62
Upside: +4.51%
LeMaitre Vascular
Nov 1, 2024
Reiterates: Outperform
Price Target: $90 → $93
Current: $82.40
Upside: +12.86%
Abbott Laboratories
Oct 8, 2024
Initiates: Outperform
Price Target: $130
Current: $133.67
Upside: -2.75%
TriSalus Life Sciences
Sep 16, 2024
Initiates: Outperform
Price Target: $10
Current: $5.07
Upside: +97.24%
Edwards Lifesciences
Sep 12, 2024
Maintains: Outperform
Price Target: $90
Current: $77.15
Upside: +16.66%
Nyxoah
Aug 7, 2024
Maintains: Outperform
Price Target: $15 → $13
Current: $7.68
Upside: +69.27%
Jul 16, 2024
Initiates: Outperform
Price Target: $135
Current: $121.87
Upside: +10.77%
Jun 25, 2024
Downgrades: Perform
Price Target: n/a
Current: $256.21
Upside: -
Aug 8, 2023
Maintains: Outperform
Price Target: $24 → $30
Current: $10.25
Upside: +192.68%
Jun 23, 2023
Maintains: Outperform
Price Target: $16 → $10
Current: $0.16
Upside: +6,023.70%
May 16, 2023
Initiates: Outperform
Price Target: $97
Current: $74.86
Upside: +29.58%
Mar 6, 2023
Reiterates: Outperform
Price Target: $28
Current: $21.48
Upside: +30.35%
Nov 29, 2022
Initiates: Outperform
Price Target: $4.5
Current: $2.02
Upside: +122.77%
Sep 24, 2021
Initiates: Outperform
Price Target: $16
Current: $2.22
Upside: +620.72%
Apr 21, 2021
Upgrades: Perform
Price Target: n/a
Current: $534.19
Upside: -
Nov 17, 2020
Upgrades: Outperform
Price Target: $660
Current: $2.20
Upside: +29,900.00%
Nov 3, 2020
Upgrades: Perform
Price Target: n/a
Current: $129.71
Upside: -
Sep 15, 2020
Initiates: Perform
Price Target: n/a
Current: $5.38
Upside: -
Jun 24, 2020
Initiates: Outperform
Price Target: $100
Current: $30.50
Upside: +227.87%
Sep 12, 2018
Upgrades: Market Perform
Price Target: n/a
Current: $85.04
Upside: -